Asymchem Laboratories (Tianjin) 

$3.2
0
+$0+0% Wednesday 13:37

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
0
市盈率
0
股息收益率
-
股息
-

即將到來

收益

25Oct預期
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
下一個
0
0.94
1.89
2.83
預期每股收益
1.3142766516
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 ASLTY 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. It has a collaboration agreement with AUM Biosciences to develop and commercialize AUM 601. The company was founded in 1999 and is headquartered in Tianjin, China. AUM Biosciences.
Show more...
首席執行官
Dr. Hao Hong Ph.D.
員工
9719
國家
CN
ISIN
US04651E1038

上市公司